HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs.

AbstractTen patients with tuberculous pericardial effusion, treated initially with adjunctive prednisone 120 mg daily, improved dramatically within a week. There were no complications. Such rapid resolution suggests that the duration of prednisone treatment for this condition could be shortened, which may be important in HIV seropositive patients.
AuthorsJ I Strang (Affiliation: Cecilia Makiwane Hospital, Mdantsane, Ciskei, South Africa.)
JournalThe Journal of infection (J Infect) Vol. 28 Issue 3 Pg. 251-4 (May 1994) ISSN: 0163-4453 [Print] ENGLAND
PMID8089513 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
  • Rifampin
  • Prednisone
  • Isoniazid
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antitubercular Agents (administration & dosage, therapeutic use)
  • Female
  • HIV Seronegativity
  • Humans
  • Isoniazid (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis (isolation & purification)
  • Pericardial Effusion (drug therapy, microbiology)
  • Pericarditis, Tuberculous (drug therapy, microbiology)
  • Prednisone (administration & dosage, therapeutic use)
  • Rifampin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD